Genialis Inc

Closed
Call
Website
177 Huntington Ave Ste 1703
Boston, MA 02115
+1 (617) 237-0085
https://www.genialis.com

Genialis Inc. is a Boston-based precision oncology company dedicated to transforming the landscape of cancer treatment through advanced AI models that facilitate biomarker discovery and therapeutic intelligence. By focusing on understanding the complexities of patient responses to treatments, Genialis aims to ensure that the most promising drug candidates become effective, life-saving medicines for cancer patients.

With a commitment to precision medicine, Genialis employs a proprietary methodology and a diverse global dataset to provide actionable insights in oncology. Through innovative solutions like Genialis krasID and Genialis ResponderID, the company addresses critical questions regarding patient outcomes and drug resistance, ultimately improving clinical success rates in cancer therapies.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
Laboratory equipment, except medical or dental, Real estate managers, Drugs acting on the respiratory system

H3 Biomedicine Inc

H3 Biomedicine Inc, based in Cambridge, is a dedicated human health care company focused on making strides in Oncology research. Their unwavering commitment is to continue the pursuit of groundbreaking advancements until the global goal of eradicating cancer is achieved. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Boston›Genialis Inc

Partial Data by Infogroup (c) 2024. All rights reserved.